Meet Biotech Stock That's Changing the Game in 2026
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
Total return indices show comprehensive performance by including dividends. Understanding them helps investors assess risk and compare strategies effectively.
27,899 articlesA smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
Supermicro, a key Nvidia partner, has not named a permanent CFO more than a year after an EY-led review urged leaders...
As volatility persists in 2026, savvy investors are exploring the tax advantages of placing Main Street Capital in a ...
Casual dining is turning a corner. Chili's posted an eye-catching 8.6% same-store sales gain, signaling a broader shi...
As macro realities fracture tech valuations, investors pivot toward durable cash flow. Meta Platforms stands out as a...
As institutional buyers step into Openlane, individual investors gain a front-row seat to a digitized used-vehicle ma...
A long-remembered jab about Chrome’s prospects resurfaces as the browser landscape continues to evolve. Here’s what i...
Long-term savers are turning to reliable income streams. Three dividend ETFs stand out for 2026, balancing yield, qua...
When SpaceX first hit the public markets, traders expected spectacle but not necessarily sustainability. A surprising...
Nokomis Capital quietly builds a new position in Apple Hospitality REIT, underscoring a rising appetite for hospitali...
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
When a notable small-cap manager exits a large stake in a data-security firm, it creates questions for investors. Thi...